GlobeNewswire by notified

Conagen unveils commercial production of high-purity non-GMO salidroside

Share

Ideal for adaptogen supplement solutions and natural preservatives in food and beverages.

Bedford, Mass., Sept. 27, 2022 (GLOBE NEWSWIRE) -- Conagen announced the commercialization of its 99% high-purity salidroside made by bioconversion technology, an active ingredient from the herbal plant Rhodiola rosea (golden root). Its strong antioxidant properties as an adaptogen are associated with reducing inflammation, protecting against oxidative stress in cells, and providing relief from depression, fatigue, and stress. Salidroside has also been used to alleviate high altitude sickness.

Unlike other salidroside products currently on the market, Conagen’s salidroside is non-GMO. Conagen leveraged its industry-leading bioconversion technology to produce clean, sustainable salidroside, identical to the compound naturally found in the Rhodiola rosea plant --- the same technology used to produce non-GMO Rebaudioside M, other steviol glycosides, and bitter blockers for sugar reduction solutions which are available from their pipeline partner, Sweegen.

Conagen’s 99% high-purity salidroside, made by bioconversion, is ideal for non-GMO supplement solutions to formulate products with a sustainable and natural consumer appeal. It is readily soluble in water and is very formulable in food and beverage applications.

“We’re reimagining the way in which rare ingredients are sourced to make them safer and higher-quality for use in health-promoting products,” said Casey Lippmeier, Ph.D., senior vice president of innovation at Conagen. “Our bioconversion technology enables us to deliver non-GMO products. Through this technology, we’re unlocking salidroside’s great potential as a powerful active health ingredient and as a tool for food and beverage producers to adopt a more natural way to preserve food and beverages.”

Food and beverage producers benefit from Conagen’s salidroside as it also possesses antimicrobial properties, making it useful as a natural preservative solution for brands seeking alternatives to artificial preservatives. Salidroside expands Conagen’s portfolio of natural preservatives, such as Taxifolin BC-DHQ® and Rosavel™ rosmarinic acid, currently available from another pipeline partner, Blue California.

Stress reduction is popular among consumers, typically addressed by exercise or indulgence in food and beverages. More consumers are taking a holistic approach to their health, including their mental well-being and sleep. They are exploring adaptogens as one of the additional positive ways to add an edge to their diets and lifestyles.

“Salidroside is one of the rare, natural molecules with proven adaptogenic activities which correlates to stress reduction,” said Lippmeier. “Initially identified in botanical extracts, adaptogens are promising new options in the quest to relieve the stress of our daily lives. This trend opens new opportunities for supplement brands and food and beverage manufacturers to adopt a health-focused profile for their products.”

Conagen accelerated salidroside production by leveraging one of its proprietary molecular platforms, which have also been used to produce the clean antioxidants hydroxytyrosol and p-coumaric acid. Salidroside is a glucoside of tyrosol. Conagen’s antimicrobial and antioxidant compounds, hydroxytyrosol and p-coumaric acid are also now available through Blue California.

The inputs of fermentation are tightly controlled, dramatically reducing the chance of contamination with heavy metals, fungal toxins, and other unsafe materials that may be found in traditional medicine preparations. Rhodiola rosea extract is most commonly used in Europe and Asia. Its medicinal use for reducing stress and depression can be traced back to the Ming Dynasty in the classic medicinal scripture Compendium of Materia Medica.

###

About Conagen

We're making the impossible possible. Conagen is a product-focused synthetic biology R&D company with large-scale manufacturing capabilities. Our scientists and engineers use the latest synthetic biology tools to develop high-quality, sustainable, nature-based products by precision fermentation and bioconversion technologies. We focus on the bioproduction of high-value ingredients for food, nutrition, flavors and fragrances, pharmaceutical, and renewable materials industries. www.conagen.com

Attachments

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Weekly share repurchase program transaction details24.4.2024 18:48:14 CEST | Press release

April 24, 2024 SBM Offshore reports the transaction details related to its EUR65 million (c. US$70 million) share repurchase program for the period April 18, 2024 through April 24, 2024. The repurchases were made under the EUR65 million share repurchase program announced on February 29, 2024 and effective from March 1, 2024. The objective of the program is to reduce share capital. Information regarding the progress of the share repurchase program and the aggregate of the transactions (calculated on a daily basis) for the period March 1, 2024 through April 24, 2024 can be found in the top half of the table below. Further detailed information regarding both the progress of the share repurchase program and all individual transactions can be accessed via the Investors section of the Company’s website. Share Repurchase ProgramOverall progress Share Repurchase Program:Total Repurchase AmountEUR 65,000,000Cumulative Repurchase AmountEUR 11,357,288Cumulative Quantity Repurchased796,226Cumulati

Vantiva - First quarter 2024 revenues24.4.2024 18:30:00 CEST | Press release

Press Release First quarter 2024 revenues Sales down 20% as reported Accelerating synergies now estimated (net of costs) at 40 million euros for 2024 and over 200 million euros from 2026 onwards GUIDANCE CONFIRMED Paris (France), April 24, 2024 - Vantiva (Euronext Paris: VANTI) today announced its unaudited sales for the first quarter of 2024. "Connected Home" sales fell by 21.7% over the quarter, despite the integration of the Home Networks business in 2024 and the contribution of the diversification activities. This is due to a strong first quarter in Q1 2023, destocking in the sector and a slowdown in capex from operators. “Supply Chain Solutions" sales were down 13.2%. Group sales totaled 458 million euros for the quarter, down 20% as reported (-19.1% at constant exchange rates). The contribution of Connected Home was 358 million euros, down 21.7% after the integration of the Home Networks business for 2024 (-20.8% at constant exchange rates). This amount includes 18 million euros

Forløb af ordinær generalforsamling.24.4.2024 18:27:38 CEST | pressemeddelelse

Nasdaq Copenhagen Silkeborg, den 24. april 2024 Fondsbørsmeddelelse nr. 6 / 2024 Vedr.: Forløb af ordinær generalforsamling. Silkeborg IF Invest A/S har onsdag den 24. april 2024 afholdt ordinær generalforsamling. Dagsordenen var følgende: 1. Bestyrelsens beretning om selskabets virksomhed i det forløbne år. 2. Fremlæggelse af årsrapport med årsberetning og revisionspåtegning. 3. Godkendelse af årsrapporten, herunder beslutning om anvendelse af overskud eller dækning af tab i henhold til den godkendte årsrapport. 4. Behandling af forslag fra kapitalejere eller bestyrelse. 5. Valg af bestyrelse. 6. Valg af 1 revisor, som skal være statsautoriseret. 7. Eventuelt. Bestyrelsens formand Henrik H. Lyhne bød velkommen og oplyste, at bestyrelsen som dirigent havde udpeget advokat Søren Egede Schulz. Dirigenten takkede for udpegningen og konstaterede, at generalforsamlingen var lovligt indkaldt og beslutningsdygtig. Inklusive fuldmagter og brevstemmer var der på generalforsamlingen repræsentere

LambdaTest Releases Accessibility DevTools Chrome Extension to Enhance Web Inclusivity24.4.2024 18:16:31 CEST | Press release

LambdaTest Accessibility DevTools Chrome Extension offers various scanning options, prioritizes critical issues for efficient resolution, and seamlessly integrates with existing workflows to enhance development efficiency, ensure compliance, and promote digital inclusivity. San Francisco, April 24, 2024 (GLOBE NEWSWIRE) -- LambdaTest, a leading cloud-based unified testing platform introduced its new Accessibility DevTools Chrome Extension. Powered by Axe-Core by Deque, this extension aims to significantly improve web accessibility, making it easier for QA testers, developers and product managers to test, manage, and report accessibility issues directly within their browsers. The LambdaTest Accessibility DevTools offers effortless accessibility scans with options like comprehensive Full Page Scans, targeted Partial Page Scans, automated Multi-Page Scans, and advanced Workflow Scans, helping to identify and address accessibility issues throughout your website. It enables swift issue disc

Adevinta ASA (ADE) - Mandatory notification of trade – Employee Share Purchase Plan24.4.2024 18:15:00 CEST | Press release

Oslo, 24 April 2024 - Employees of Adevinta ASA have on the 22th of April 2024 received a total of 33,454 gross Adevinta treasury shares. After withholding tax, a total of 17,270 shares were sold at a price of 113.801742 NOK per share to cover tax responsibilities and the net number of shares to be transferred to the employees will be 16,184 shares. The net shares will be transferred to the participants in the coming days. This transaction is related to bonus matching shares given to employees who enrolled in the Employee Share Saving Plan (ASPP) for Q1 of 2022. Part of the transaction included primary insiders in Adevinta ASA. The notifications of the transaction are attached to this press release in accordance with MAR regulation. The purpose of Adevinta’s employee share purchase plan is to motivate and retain employees as well as to increase the interest in Adevinta’s result and performance through owning Adevinta shares. After two years of ownership, the company will allocate one b

HiddenA line styled icon from Orion Icon Library.Eye